Depomed’s Proquin XR Ciprofloxacin Formulation Clears FDA

Proquin XR’s more gradual release of dosage leads to a more advantageous adverse event profile than other ciprofloxacin products, Depomed says. The company is seeking a marketing partner and expects to launch its extended-release ciprofloxacin by year-end.